🇺🇸 FDA
Patent

US 11738019

Substituted heterocycles as antiviral agents

granted A61KA61K31/4725A61K38/21

Quick answer

US patent 11738019 (Substituted heterocycles as antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4725, A61K38/21